Results 1 to 10 of about 128 (50)

Decreased growth differentiation factor 9, bone morphogenetic protein 15, and forkhead box O3a expressions in the ovary via ulipristal acetate. [PDF]

Rev Assoc Med Bras (1992), 2023
Fındık DG, Kaplanoğlu GT, Arık GN, Alemari NBA.   +3 more
europepmc   +1 more source

Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis‑associated chronic pelvic pain. [PDF]

BMC Womens Health, 2022
Caruso S, Cianci A, Iraci Sareri M, Panella M, Caruso G, Cianci S.   +5 more
europepmc   +1 more source

Investigation of Inherited Chromosomally Integrated Human Herpesvirus-6A+ and -6B+ in a Patient with Ulipristal Acetate-Induced Fulminant Hepatic Failure. [PDF]

Viruses, 2021
Izquierdo L, Canivet CM, De Martin E, Antonini TM, Roque-Afonso AM, Coilly A, Deback C.   +6 more
europepmc   +1 more source

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate. [PDF]

Hum Mol Genet, 2023
Kolterud Å, Välimäki N, Kuisma H, Patomo J, Ilves ST, Mäkinen N, Kaukomaa J, Palin K, Kaasinen E, Karhu A, Pasanen A, Bützow R, Heikinheimo O, Kopp Kallner H, Aaltonen LA.   +14 more
europepmc   +1 more source

The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation. [PDF]

Breast Cancer Res Treat, 2022
Westhoff CL, Guo H, Wang Z, Hibshoosh H, Polaneczky M, Pike MC, Ha R.   +6 more
europepmc   +1 more source

Pilot Data on the Feasibility And Clinical Outcomes of a Nomegestrol Acetate Oral Contraceptive Pill in Women With Premenstrual Dysphoric Disorder. [PDF]

Front Endocrinol (Lausanne), 2021
Robertson E, Thew C, Thomas N, Karimi L, Kulkarni J.   +4 more
europepmc   +1 more source

Unprotected intercourse in the 2 weeks prior to quick-start initiation of an etonogestrel contraceptive implant with and without use of oral emergency contraception. [PDF]

Am J Obstet Gynecol, 2020
Gawron LM, Gero A, Kushner KL, Turok DK, Sanders JN.   +4 more
europepmc   +1 more source

Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic! [PDF]

Eur J Obstet Gynecol Reprod Biol, 2020
Rozenberg S, Revercez P, Fastrez M, Vandromme J, Bucella D.   +4 more
europepmc   +1 more source

Dispensing and practice use patterns, facilitators and barriers for uptake of ulipristal acetate emergency contraception in British Columbia: a mixed-methods study. [PDF]

CMAJ Open, 2021
Chan MC, Munro S, Schummers L, Albert A, Mackenzie F, Soon JA, Ragsdale P, Fitzsimmons B, Renner R.   +8 more
europepmc   +1 more source

Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids. [PDF]

Hum Reprod, 2022
Middelkoop MA, de Lange ME, Clark TJ, Mol BWJ, Bet PM, Huirne JAF, Hehenkamp WJK.   +6 more
europepmc   +1 more source